A new four-drug combination is highly effective and safe in patients with newly diagnosed multiple myeloma, according to data presented at the annual meeting of the American Society of Clinical ...

A new four-drug combination is highly effective and safe in patients with newly diagnosed multiple myeloma, according to data ...

In the two decades since a young father was diagnosed with multiple myeloma, clinical trials and advances in treating his ...

Carfilzomib-based induction/consolidation with or without autologous transplant (ASCT) followed by lenalidomide (R) or carfilzomib-lenalidomide (KR) maintenance: Efficacy in high-risk patients. This ...